TrialCancer medicine2025

Correlation Between Treatment-Related Adverse Events and Efficacy of Camrelizumab in Combination With Apatinib in Patients With Unresectable Hepatocellular Carcinoma.

Ting Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.